Surrounding OPEP therapy, the standard of care for airway clearance
- Incentive Positive Expiratory Pressure Therapy
U.S. Patent 9,233,24 B2 and other patents pending
D R Burton OPEP products feature superior performance
A published study challenges the traditional OPEP therapy as a blind technique involving no measures of effectiveness.
In OPEP therapy patients are simply instructed to take a deeper breath than normal and exhale through the device for 3-4 seconds. A published study challenges traditional OPEP therapy as a blind technique involving no measures of feedback or effectiveness. The study found that 60% of subjects (25/42) performed either an inadequate inspiratory maneuver or exceeded the recommended inspiratory volume during OPEP therapy. Only 40% of subjects (17/42) were in the recommended range of 51-70% of predicted inspiratory capacity (see chart 2).
The study also found that when resistance was set at the most common “mid-level”, only 43% of subjects (18/42) produced positive expiratory pressures in the effective range of 10 – 20 cmH2O (see chart 3).
– The simplest OPEP therapy